Clinical Neuropharmacology · 2007 · 26 citations · 14 references
MedicineNeurologyErgonomicsFunctional Movement AssessmentMovement DisordersParkinson DiseaseParkinsonian DisordersSymptom CharacterizationClinical Diagnosis Of ParkinsonismCochran's Q TestQuestionnaire ReliabilityQuestionnaire ValidityUnified Parkinson's Disease Rating Scale
This study sought to evaluate the feasibility and performance of the Patient Card (PC), an instrument derived from the Patient Questionnaire by Stacy et al, for detection of wearing-off (W-O), in a very first application to a Spanish population with Parkinson disease. Patients were classified as experiencing W-O on the basis of the clinician's Follow-up Questionnaire, the Unified Parkinson Disease Rating Scale-Item 36, or improvement, after the following scheduled dose of medication, of 1 or more symptoms included in the PC. The highest proportion of patients with W-O was identified by the PC (79.8%), followed by the Follow-up Questionnaire (55.4%), and Unified Parkinson Disease Rating Scale (35.1%) (Cochran Q, P < 0.01). The PC Spanish version performed adequately, capturing W-O symptoms more frequently than did the other methods, as in the original Patient Questionnaire study by Stacy et al. Accordingly, the PC may potentially help clinicians identify W-O phenomena and thereby allow for better management of patients with Parkinson disease.
14
Margaret M. Hoehn, Melvin D. Yahr · Neurology · 1967 · 12K citations · Full text
Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial
Robert G. Holloway, Ira Shoulson, Karl Kieburtz et al. · JAMA · 2000 · 802 citations
Medicine, Neurology, Pharmacotherapy +12
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
Parkinson Study Group · JAMA · 2000 · 764 citations
Nonmotor fluctuations in Parkinson’s disease
Tatiana Witjas, Elsa Kaphan, J.-P. Azulay et al. · Neurology · 2002 · 630 citations